Vimarsana
Biggest News Aggregation in the World

Page 2 - Chronic Back News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chronic Back. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chronic Back Today - Breaking & Trending Today

Best CBD Oil for Pain: Top 15 Brands of 2022 - Vimarsana News

Best CBD Oil for Pain: Top 15 Brands of 2022

Let's take a deep dive into the causes of pain and the ways that CBD oil can help to calm both chronic and acute pain.

Saluda Medical Announces Robust Scientific Presence at 2022 International Neuromodulation Society (INS) World Congress - Vimarsana News

Saluda Medical Announces Robust Scientific Presence at 2022 International Neuromodulation Society (INS) World Congress

/PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain - Vimarsana News

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain

MINNEAPOLIS, Feb. 15, 2022 /PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of ...

Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine - Vimarsana News

Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine

REDWOOD CITY, Calif., Feb. 11, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, li...

Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine - Vimarsana News

Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...